InMed Pharmaceuticals Synthesizes Rare Cannabinoids To Treat Glaucoma, Skin DiseaseSeeking Alpha • 04/12/21
InMed Pharmaceuticals to Participate in 2021 Cannabinoid-Derived Pharmaceuticals Industry Review Summit EuropePRNewsWire • 01/19/21
InMed Announces Results of Second Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy SubjectsPRNewsWire • 01/08/21